Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark A. Bobko
Mark A. Bobko
Bayer Corporation
Chemistry
Biochemistry
Organic chemistry
Syk
Bicyclic molecule
4
Papers
96
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK).
2003
Bioorganic & Medicinal Chemistry Letters
Charles L. Cywin
Bao-Ping Zhao
Daniel W. McNeil
Matt Hrapchak
Anthony S. Prokopowicz
Daniel R. Goldberg
Tina Marie Morwick
Amy Gao
Scott Jakes
Mohammed A. Kashem
Ronald L. Magolda
Richard Soll
Mark R. Player
Mark A. Bobko
James M Rinker
Renee L. DesJarlais
Michael P. Winters
Show All
Source
Cite
Save
Citations (46)
Derives de 1,6 naphtyridine utiles en tant qu'inhibiteurs de la kinase syk
2002
Charles L. Cywin
Scott Jakes
Joachim Heider
Mark A. Bobko
Jarlais Renee L. Des
Mark R. Player
James M Rinker
Michael P. Winters
Bao-Ping Zhao
Show All
Source
Cite
Save
Citations (0)
Solid-phase synthesis of a library of piperazinediones and diazepinediones via kaiser oxime resin
1998
Bioorganic & Medicinal Chemistry Letters
Roger A. Smith
Mark A. Bobko
Wendy Lee
Show All
Source
Cite
Save
Citations (42)
CD45 protein tyrosine phosphatase: Determination of minimal peptide length for substrate recognition and synthesis of some tyrosine-based electrophiles as potential active-site directed irreversible inhibitors
1995
Bioorganic & Medicinal Chemistry Letters
Mark A. Bobko
Henry R. Wolfe
Ashis K. Saha
Roland E. Dolle
Diana K. Fisher
Terry J. Higgins
Show All
Source
Cite
Save
Citations (8)
1